PANE, CHIARA
 Distribuzione geografica
Continente #
AS - Asia 1.450
EU - Europa 1.301
NA - Nord America 1.075
SA - Sud America 229
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.100
Nazione #
US - Stati Uniti d'America 1.027
SG - Singapore 743
RU - Federazione Russa 607
CN - Cina 355
IT - Italia 335
BR - Brasile 181
HK - Hong Kong 129
VN - Vietnam 118
DE - Germania 74
NL - Olanda 61
GB - Regno Unito 43
FI - Finlandia 40
FR - Francia 31
IE - Irlanda 27
IN - India 27
CA - Canada 25
AR - Argentina 19
KR - Corea 18
MX - Messico 17
BD - Bangladesh 14
BG - Bulgaria 13
EC - Ecuador 13
CI - Costa d'Avorio 12
SE - Svezia 12
AT - Austria 10
ZA - Sudafrica 10
ES - Italia 8
PL - Polonia 8
TR - Turchia 8
UA - Ucraina 8
IQ - Iraq 7
JP - Giappone 7
CO - Colombia 6
MA - Marocco 6
MK - Macedonia 5
CH - Svizzera 4
ID - Indonesia 4
PH - Filippine 4
AL - Albania 3
BE - Belgio 3
CL - Cile 3
EG - Egitto 3
KE - Kenya 3
PK - Pakistan 3
AZ - Azerbaigian 2
ET - Etiopia 2
IR - Iran 2
PY - Paraguay 2
RO - Romania 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GF - Guiana Francese 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
RW - Ruanda 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VC - Saint Vincent e Grenadine 1
YE - Yemen 1
YT - Mayotte 1
ZW - Zimbabwe 1
Totale 4.100
Città #
Singapore 368
Moscow 151
Chandler 143
Hong Kong 128
Ashburn 124
Beijing 103
Hefei 103
Santa Clara 57
Naples 51
Ho Chi Minh City 44
Amsterdam 42
Seattle 29
San Jose 28
Millbury 26
Nanjing 25
Dallas 24
Munich 24
Hanoi 23
Los Angeles 22
The Dalles 20
Dearborn 18
Des Moines 18
Milan 18
Seoul 18
Napoli 17
Boston 16
Buffalo 16
Princeton 16
São Paulo 16
Turku 16
Redondo Beach 14
Nola 13
New York 12
Rome 12
Sofia 12
Bollate 11
Frankfurt am Main 11
Lawrence 10
Norwalk 10
Helsinki 9
Mexico City 9
Toronto 9
Cava De' Tirreni 8
Chicago 8
Dublin 8
Stockholm 8
Biên Hòa 7
Denver 7
Gricignano di Aversa 7
Le Cannet 7
Montreal 7
Poplar 7
Warsaw 7
Wilmington 7
Atlanta 6
Curitiba 6
Haiphong 6
Houston 6
Johannesburg 6
London 6
Phoenix 6
Pune 6
Vienna 6
Bexley 5
Falkenstein 5
Giugliano in Campania 5
Monteforte Irpino 5
Mumbai 5
Nuremberg 5
Padova 5
Quito 5
Tianjin 5
Afragola 4
Baghdad 4
Belo Horizonte 4
Brooklyn 4
Can Tho 4
Columbus 4
Dong Ket 4
Fairfield 4
Florence 4
Izmir 4
Latina 4
Lviv 4
Manchester 4
Orem 4
Ottawa 4
Redwood City 4
Rio de Janeiro 4
Roubaix 4
San Francisco 4
Torre Annunziata 4
Turin 4
Washington 4
Barcellona Pozzo di Gotto 3
Battipaglia 3
Bitola 3
Brasília 3
Brussels 3
Campinas 3
Totale 2.129
Nome #
A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients 139
GAA-FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response 139
A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2. 137
Emotion Recognition and Psychological Comorbidity in Friedreich’s Ataxia 132
Cerebellum and cognition in Friedreich ataxia: a voxel-based morphometry and volumetric MRI study 132
Long-term effect of epoetin alfa on clinical and biochemical markers in friedreich ataxia 131
Prevalence and features of non-motor symptoms in Wilson's disease 127
Dimethyl Fumarate Mediates Nrf2-dependent Mitochondrial Biogenesis in Mice and Humans 126
Rationale and protocol of a double-blind, randomized, placebo-controlled trial to test the efficacy, safety, and tolerability of dimethyl fumarate in Friedreich Ataxia (DMF-FA-201) 125
Screening for Fabry disease in a series of Parkinson’s disease patients and literature review 125
The C-Terminal Cross-linked Telopeptide of Type I Collagen (CTX-I) as a Potential Cardiomyopathy Biomarker in Friedreich Ataxia Patients 124
The use of medical-grade cannabis in patients non-responders to Nabiximols 124
Lamivudine and fingolimod co-administration in two patients with multiple sclerosis and occult hepatitis B virus infection 118
Safety and feasibility of upper limb cardiopulmonary exercise test in Friedreich ataxia 115
Application of the p9NORM correction method to timed neuropsychological tests in Parkinson's disease and multiple system atrophy. 113
Adult normative values for the PATA Rate Test 112
A randomized clinical trial of lithium in multiple system atrophy. 111
Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich’s Ataxia 111
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial 110
Peripheral markers of autophagy in polyglutamine diseases 110
Stability of erythropoietin repackaging in polypropylene syringes for clinical use 109
Motor and non-motor features in Parkinson's Disease patients carrying GBA gene mutations 105
Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests 105
Mobitz type I and II atrioventricular blocks during fingolimod therapy 104
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests 101
The Multiple Faces of Spinocerebellar Ataxia type 2 98
Screening for RFC-1 pathological expansion in late-onset ataxias: a contribution to the differential diagnosis. 96
A new genetic cause of spastic ataxia: the p.Glu415Lys variant in TUBA4A 95
Othello syndrome in Parkinson's disease: a systematic review and report of a case series 94
Conventional MRI findings in hereditary degenerative ataxias: a pictorial review 94
Fingolimod first dose safety in clinical practice. 90
Gradient of microstructural damage along the dentato‐thalamo‐cortical tract in Friedreich ataxia 86
Dissociative Identity Disorder: Restoration of Executive Functions After Switch from Alter to Host Personality. 86
Correction to: Peripheral markers of autophagy in polyglutamine diseases (Neurological Sciences, (2018), 39, 1, (149-152), 10.1007/s10072-017-3156-6) 85
Efficacy of innovative therapies in myasthenia gravis: A systematic review, meta-analysis and network meta-analysis 77
Altered Intracerebellar Functional Connectivity in Friedreich's Ataxia: A Graph-Theory Functional MRI Study 68
Ataxia and Hypogonadism: a Review of the Associated Genes and Syndromes. 64
Brain Structure and Degeneration Staging in Friedreich Ataxia: Magnetic Resonance Imaging Volumetrics from the ENIGMA-Ataxia Working Group 62
The use of medical grade cannabis in Italy for drug-resistant epilepsy: a case series 48
Nonvascular Parkinsonism in Fabry Disease: Results from Magnetic Resonance and Dopamine Transporter Imaging 43
null 23
Totale 4.194
Categoria #
all - tutte 13.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.224


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 2 2 8 0 6 5
2021/2022188 3 6 1 1 5 10 6 5 31 13 37 70
2022/2023344 36 37 13 19 40 33 9 28 58 52 16 3
2023/2024256 7 33 17 21 14 25 13 55 7 2 32 30
2024/20251.367 51 31 9 30 63 63 163 94 95 121 528 119
2025/20261.714 251 276 307 271 463 123 23 0 0 0 0 0
Totale 4.194